- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
BrainAurora Medical Technology Ltd (6681)
BrainAurora Medical Technology Ltd stock price live, this page displays HK 6681 stock exchange data. View the 6681 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the BrainAurora Medical Technology Ltd real time stock price chart below.
What Is the BrainAurora Medical Technology Ltd Stock Price Today?
The BrainAurora Medical Technology Ltd stock price today is 1.55.
What Is the Stock Symbol for BrainAurora Medical Technology Ltd?
The stock symbol for BrainAurora Medical Technology Ltd is "6681."
What Stock Exchange Does BrainAurora Medical Technology Ltd Trade On?
BrainAurora Medical Technology Ltd is listed and trades on the Hong Kong stock exchange.
Is BrainAurora Medical Technology Ltd a Good Stock to Buy?
Determining whether BrainAurora Medical Technology Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 6681 quote. (ISIN: KYG1300R1083)
What Is the BrainAurora Medical Technology Ltd Stock Price Today?
The BrainAurora Medical Technology Ltd stock price today is 1.55.
What Is the Stock Symbol for BrainAurora Medical Technology Ltd?
The stock symbol for BrainAurora Medical Technology Ltd is "6681."
What Stock Exchange Does BrainAurora Medical Technology Ltd Trade On?
BrainAurora Medical Technology Ltd is listed and trades on the Hong Kong stock exchange.
Is BrainAurora Medical Technology Ltd a Good Stock to Buy?
Determining whether BrainAurora Medical Technology Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 6681 quote. (ISIN: KYG1300R1083)
Hong Kong
Currency in HKD
1.55
+0.02(+1.31%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.51
1.56
52 wk Range
1.41
17.79
6681 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.511.56
52 wk Range
1.4117.79
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
6681 Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Strong Buy
Price Target
8.05
Upside
+419.07%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales growth in the current year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 8.05
(+419.07% Upside)
Earnings
Latest Release
Mar 31, 2026
EPS / Forecast
-0.16 / --
Revenue / Forecast
120M / --
Compare 6681 to Peers and Sector
Metrics to compare | 6681 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship6681PeersSector | |
|---|---|---|---|---|
P/E Ratio | −5.7x | 28.6x | −0.4x | |
PEG Ratio | 0.32 | 0.06 | 0.00 | |
Price/Book | 18.3x | 2.7x | 2.6x | |
Price / LTM Sales | 8.1x | 7.3x | 3.1x | |
Upside (Analyst Target) | - | 54.6% | 47.9% | |
Fair Value Upside | Unlock | 3.8% | 6.3% | Unlock |
BrainAurora Medical Technology Limited provides system integral software solutions for hospitals and research projects in Mainland China. The company develops medical-grade digital therapy (DTx) products for cognitive impairment. It offers the evaluation and intervention of cognitive impairments to treat vascular diseases, neurodegenerative diseases, psychiatric disorders, and child development deficiencies. The company develops the Brain Function Information Management Platform software system, an evidence-based, medical-grade DTx product; Basic Cognitive Testing Software, an assessment of patients for basic cognitive capacity; Cognitive Ability Supplemental screening and assessment software, a solution designed to facilitate healthcare professionals assessment of patients; and Dyslexia Supplemental Screening and Assessment Software, a solution designed to facilitate the assessment of risk of developmental dyslexia in children. It also develops dyslexia adjunctive recovery training software; quantitative cognitive assessment software for depression; depression treatment software; and cognitive impairment assessment software and cognitive impairment treatment software solutions, as well as bone trauma and pain cognitive impairment digital therapeutics product. In addition, the company provides marketing services. BrainAurora Medical Technology Limited was founded in 2012 and is headquartered in Shaoxing, China.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the BrainAurora Medical Technology (6681) Stock Price Today?
The BrainAurora Medical Technology stock price today is 1.55 HKD.
What Stock Exchange Does BrainAurora Medical Technology Trade On?
BrainAurora Medical Technology is listed and trades on the Hong Kong Stock Exchange.
What Is the Stock Symbol for BrainAurora Medical Technology?
The stock symbol for BrainAurora Medical Technology is "6681."
What Is the BrainAurora Medical Technology Market Cap?
As of today, BrainAurora Medical Technology market cap is 2.11B HKD.
What Is BrainAurora Medical Technology's Earnings Per Share (TTM)?
The BrainAurora Medical Technology EPS (TTM) is -0.27.
From a Technical Analysis Perspective, Is 6681 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.
How Many Times Has BrainAurora Medical Technology Stock Split?
BrainAurora Medical Technology has split 0 times.
What is the current trading status of BrainAurora Medical Technology (6681)?
As of Aug 17, 2026, BrainAurora Medical Technology (6681) is trading at a price of 1.55 HKD, with a previous close of 1.55 HKD. The stock has fluctuated within a day range of 1.51 HKD to 1.56 HKD, while its 52-week range spans from 1.41 HKD to 17.79 HKD.
What Is BrainAurora Medical Technology (6681) Price Target According to Analysts?
The average 12-month price target for BrainAurora Medical Technology is 8.05 HKD, with a high estimate of 8.04565894 HKD and a low estimate of 8.04565894 HKD. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +419.07% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.